title: Treat early and embrace the evidence in favour of anti-TNF-alpha therapy for Behçet's uveitis.
authors.forename: Richard W J
authors.initials: RW
authors.lastname: Lee
authors.forename: Andrew D
authors.initials: AD
authors.lastname: Dick
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001528:Behcet Syndrome / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014605:Uveitis / Q000188:drug therapy*
chemical_list: D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab